BOLD

Boundless Bio (BOLD)

Boundless Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BOLD

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/25	21 : 00	GlobeNewswire Inc.	Boundless Bio to Participate in the Piper Sandler Healthcare Conference	NASDAQ:BOLD	Boundless Bio Inc
2024/11/08	06 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BOLD	Boundless Bio Inc
2024/11/08	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BOLD	Boundless Bio Inc
2024/11/08	06 : 01	GlobeNewswire Inc.	Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights	NASDAQ:BOLD	Boundless Bio Inc
2024/11/05	21 : 00	GlobeNewswire Inc.	Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference	NASDAQ:BOLD	Boundless Bio Inc
2024/10/15	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BOLD	Boundless Bio Inc
2024/10/14	21 : 00	GlobeNewswire Inc.	Boundless Bio Announces Departure of Chief Financial Officer	NASDAQ:BOLD	Boundless Bio Inc
2024/09/11	20 : 00	GlobeNewswire Inc.	Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference	NASDAQ:BOLD	Boundless Bio Inc
2024/08/21	08 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BOLD	Boundless Bio Inc
2024/08/21	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BOLD	Boundless Bio Inc
2024/08/13	05 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BOLD	Boundless Bio Inc
2024/08/13	05 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BOLD	Boundless Bio Inc
2024/08/13	05 : 01	GlobeNewswire Inc.	Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results	NASDAQ:BOLD	Boundless Bio Inc
2024/06/05	20 : 00	Business Wire	Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:BOLD	Boundless Bio Inc
2024/05/13	20 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BOLD	Boundless Bio Inc
2024/05/13	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BOLD	Boundless Bio Inc
2024/05/13	20 : 00	Business Wire	Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights	NASDAQ:BOLD	Boundless Bio Inc
2024/05/06	21 : 00	Business Wire	Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024	NASDAQ:BOLD	Boundless Bio Inc
2024/04/11	21 : 00	Business Wire	Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications	NASDAQ:BOLD	Boundless Bio Inc
2024/04/08	21 : 00	Business Wire	Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024	NASDAQ:BOLD	Boundless Bio Inc
2020/02/15	07 : 23	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2020/02/15	06 : 35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2020/02/15	06 : 15	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2020/02/12	06 : 41	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BOLD	Boundless Bio Inc
2020/02/06	01 : 27	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2020/01/27	23 : 38	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:BOLD	Boundless Bio Inc
2020/01/21	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BOLD	Boundless Bio Inc
2020/01/21	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BOLD	Boundless Bio Inc
2019/12/04	09 : 13	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.	NASDAQ:BOLD	Boundless Bio Inc
2019/12/03	08 : 01	Business Wire	Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics	NASDAQ:BOLD	Boundless Bio Inc